GLP-1 receptor agonists and thyroid C-cell concerns — evidence review

carl_compliance said:

The mechanism is more central than most summaries suggest.

This answered a question I did not know how to ask. Sending this to two other people who asked me the same thing last week.

From the other side of the consultation, briefly. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

PeptideChemSF said:

It helps to ask what evidence would change your mind before you look at any.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

The figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Carry on.